Page last updated: 2024-09-03

mci 154 and Constriction, Pathological

mci 154 has been researched along with Constriction, Pathological in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamakawa, H; Yokoyama, M	1

Other Studies

1 other study(ies) available for mci 154 and Constriction, Pathological

Article	Year
Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts. Journal of the American College of Cardiology, 1997, Mar-01, Volume: 29, Issue:3 Topics: Aged; Cardiotonic Agents; Constriction, Pathologic; Coronary Disease; Dobutamine; Energy Metabolism; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure	1997

Article

Year

Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.

Journal of the American College of Cardiology, 1997, Mar-01, Volume: 29, Issue:3

Topics: Aged; Cardiotonic Agents; Constriction, Pathologic; Coronary Disease; Dobutamine; Energy Metabolism; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure

1997